Cargando…

Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals

Four azo dyes known to form anionic complexes with V(V) were investigated as potential liquid–liquid extraction–spectrophotometric reagents for the antihistamine medication hydroxyzine hydrochloride (HZH). A stable ion-association complex suitable for analytical purposes was obtained with 6-hexyl-4-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirova, Gergana Kirilova, Velkova, Zdravka Yancheva, Delchev, Vassil Borisov, Gavazov, Kiril Blazhev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051179/
https://www.ncbi.nlm.nih.gov/pubmed/36985455
http://dx.doi.org/10.3390/molecules28062484
_version_ 1785014815289245696
author Kirova, Gergana Kirilova
Velkova, Zdravka Yancheva
Delchev, Vassil Borisov
Gavazov, Kiril Blazhev
author_facet Kirova, Gergana Kirilova
Velkova, Zdravka Yancheva
Delchev, Vassil Borisov
Gavazov, Kiril Blazhev
author_sort Kirova, Gergana Kirilova
collection PubMed
description Four azo dyes known to form anionic complexes with V(V) were investigated as potential liquid–liquid extraction–spectrophotometric reagents for the antihistamine medication hydroxyzine hydrochloride (HZH). A stable ion-association complex suitable for analytical purposes was obtained with 6-hexyl-4-(2-thiazolylazo)resorcinol (HTAR). The molar absorption coefficient, limit of detection, linear working range, and relative standard deviation in the analysis of real pharmaceutical samples (tablets and syrup) were 3.50 × 10(4) L mol(−1) cm(−1), 0.13 μg mL(−1), 0.43–12.2 μg mL(−1), and ≤2.7%, respectively. After elucidating the molar ratio in the extracted ion-association complex (HZH:V = 1:1), the ground-state equilibrium geometries of the two constituent ions—HZH(+) and [VO(2)(HTAR)](−)—were optimized at the B3LYP level of theory using 6-311++G** basis functions. The cation and anion were then paired in four different ways to find the most likely structure of the extracted species. In the lowest-energy structure, the VO(2) group interacts predominantly with the heterochain of the cation. A hydrogen bond is present (V–O···H–O; 1.714 Å) involving the terminal oxygen of this chain.
format Online
Article
Text
id pubmed-10051179
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100511792023-03-30 Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals Kirova, Gergana Kirilova Velkova, Zdravka Yancheva Delchev, Vassil Borisov Gavazov, Kiril Blazhev Molecules Article Four azo dyes known to form anionic complexes with V(V) were investigated as potential liquid–liquid extraction–spectrophotometric reagents for the antihistamine medication hydroxyzine hydrochloride (HZH). A stable ion-association complex suitable for analytical purposes was obtained with 6-hexyl-4-(2-thiazolylazo)resorcinol (HTAR). The molar absorption coefficient, limit of detection, linear working range, and relative standard deviation in the analysis of real pharmaceutical samples (tablets and syrup) were 3.50 × 10(4) L mol(−1) cm(−1), 0.13 μg mL(−1), 0.43–12.2 μg mL(−1), and ≤2.7%, respectively. After elucidating the molar ratio in the extracted ion-association complex (HZH:V = 1:1), the ground-state equilibrium geometries of the two constituent ions—HZH(+) and [VO(2)(HTAR)](−)—were optimized at the B3LYP level of theory using 6-311++G** basis functions. The cation and anion were then paired in four different ways to find the most likely structure of the extracted species. In the lowest-energy structure, the VO(2) group interacts predominantly with the heterochain of the cation. A hydrogen bond is present (V–O···H–O; 1.714 Å) involving the terminal oxygen of this chain. MDPI 2023-03-08 /pmc/articles/PMC10051179/ /pubmed/36985455 http://dx.doi.org/10.3390/molecules28062484 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kirova, Gergana Kirilova
Velkova, Zdravka Yancheva
Delchev, Vassil Borisov
Gavazov, Kiril Blazhev
Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title_full Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title_fullStr Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title_full_unstemmed Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title_short Vanadium-Containing Anionic Chelate for Spectrophotometric Determination of Hydroxyzine Hydrochloride in Pharmaceuticals
title_sort vanadium-containing anionic chelate for spectrophotometric determination of hydroxyzine hydrochloride in pharmaceuticals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051179/
https://www.ncbi.nlm.nih.gov/pubmed/36985455
http://dx.doi.org/10.3390/molecules28062484
work_keys_str_mv AT kirovagerganakirilova vanadiumcontaininganionicchelateforspectrophotometricdeterminationofhydroxyzinehydrochlorideinpharmaceuticals
AT velkovazdravkayancheva vanadiumcontaininganionicchelateforspectrophotometricdeterminationofhydroxyzinehydrochlorideinpharmaceuticals
AT delchevvassilborisov vanadiumcontaininganionicchelateforspectrophotometricdeterminationofhydroxyzinehydrochlorideinpharmaceuticals
AT gavazovkirilblazhev vanadiumcontaininganionicchelateforspectrophotometricdeterminationofhydroxyzinehydrochlorideinpharmaceuticals